Onderstaande artikelen zijn gepubliceerd door NVKFAZ-leden. Oudere artikelen die eerder in 'Extract' werden gepubliceerd vindt u onder 'Extract artikelen'. De titels van de artikelen zijn gelinked naar (een abstract van) het artikel op de site van het betreffende tijdschrift, of naar het volledige artikel op de

jjjj/mm  titel tijdschrift 
2015 The relation of the number of hydrogen bond acceptors with recoveries of immunosuppressants in dried blood spot analysis. Bioanalysis
2015 Dried blood spot analysis; facing new challenges is. Bioanalysis
2015 What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis? Bioanalysis
2015 Dried blood spot analysis of creatinine with LC-MS/MS in addition to immunosuppressants analysis. Anal. Bioanal Chem. 
2015 Analysis of remifentanil with liquid chromatography-tandem mass spectrometry and an extensive stability investigation in EDTA whole blood and acidified EDTA plasma. Anesth. Analg. 
2015 The performance of five different dried blood spot cards for the analysis of six immunosuppressants. Bioanalysis
2015 Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples Bioanalysis 
2014 Quantification of amikacin and kanamycin in serum using a simple and validated LC-MS/MS method. Bioanalysis
2014 Fast and highly selective LC-MS/MS screening for THC and 16 other abused drugs and metabolites in human hair to monitor patients for drug abuse. Ther. Drug Monit.
2014 Application of sweat patch screening for 16 drugs and metabolites using a fast and highly selective LC-MS/MS method. Ther. Drug Monit. 
2014 Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clin. Pharmacokinet. and future directions.
2014 Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC-MS/MS. Talanta >
2014/09 Therapeutic Drug Monitoring by Dried Blood Spot: Progress to Date and Future Directions Clin Pharmacokinet

Fast LC-MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery.

Talanta /span>

Troubleshooting carry-over of LC-MS/MS method for rifampicin, clarithromycin and metabolites in human plasma.

J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci.

Bispectral index values and propofol concentrations at loss and return of consciousness in patients with frontal
brain tumours and control patients

(GCMS propofol analyse in plasma)

Britisch Journal of Anaesthesia
2012 Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Antimicrob. Agents Chemother.
2011 Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. J. Chromatogr. B. Analyt Technol. Biomed. Life. Sci.
2009 Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther. Drug Monit.
2007/10 Onderzoekje (analyse UMCG, H. Kuiper) naar anti-luchtziektepillen, die gebruikt zijn tijdens WO-II voor de “D-Day jump”

Post-mortem cases involving amphetamine-based drugs in the Netherlands: Comparison with driving under the influence cases

Forensic Science International

Gas chromatography–mass spectrometric assay for propofol in cerebrospinal fluid of traumatic brain patients
(GCMS propofol analyse in liquor)

Journal of Chromatography

Drug use and the severity of a traffic accident

Accident Analysis and Prevention

Driving under the influence of alcohol and/or drugs in the Netherlands 1995–1998 in view of the German and Belgian legislation

Forensic Science International